TELA Bio (TELA) EPS (Weighted Average and Diluted) (2019 - 2026)
TELA Bio's quarterly EPS (Weighted Average and Diluted) came in at -$0.21 in Q1 2026, up 16.0% year-on-year from -$0.18 in Q1 2025, and down 23.53% quarter-over-quarter from -$0.17 in Q4 2025.
TELA Bio has reported EPS (Weighted Average and Diluted) for 8 years, with the latest figure at -$0.21 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Weighted Average and Diluted) rose 16.0% year-over-year to -$0.21; the trailing twelve-month figure through Mar 2026 stood at -$0.79 (up 41.48% YoY), and the FY2025 full-year result was -$0.83, up 37.59% from the prior year.
- EPS (Weighted Average and Diluted) for Q1 2026 stood at -$0.21, down from -$0.17 in the prior quarter.
- The five-year high for EPS (Weighted Average and Diluted) was -$0.17 in Q4 2025, with the low at -$0.88 in Q2 2022.
- Average EPS (Weighted Average and Diluted) over 5 years is -$0.42, with a median of -$0.45 recorded in 2023.
- Year-over-year, EPS (Weighted Average and Diluted) plunged 54.39% in 2022 and soared 67.92% in 2024.
- Tracing TELA's EPS (Weighted Average and Diluted) over 5 years: stood at -$0.48 in 2022, then fell by 10.42% to -$0.53 in 2023, then soared by 67.92% to -$0.17 in 2024, then grew by 0.0% to -$0.17 in 2025, then dropped by 23.53% to -$0.21 in 2026.
- The last three EPS (Weighted Average and Diluted) figures came in at -$0.21 (Q1 2026), -$0.17 (Q4 2025), and -$0.19 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.61 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 1.93 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.89 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.90 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.66 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 0.51 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.85 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 2.24 |
| 10 | TELA Bio | 13.26 Mn | -26.28 Mn | 12.52 Mn | -0.21 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.21 |
| Dec 31, 2025 | -0.17 |
| Sep 30, 2025 | -0.19 |
| Jun 30, 2025 | -0.22 |
| Mar 31, 2025 | -0.25 |
| Dec 31, 2024 | -0.17 |
| Sep 30, 2024 | -0.42 |
| Jun 30, 2024 | -0.51 |
| Mar 31, 2024 | -0.23 |
| Dec 31, 2023 | -0.53 |
| Sep 30, 2023 | -0.45 |
| Jun 30, 2023 | -0.46 |
| Mar 31, 2023 | -0.63 |
| Dec 31, 2022 | -0.48 |
| Sep 30, 2022 | -0.64 |
| Jun 30, 2022 | -0.88 |
| Mar 31, 2022 | -0.75 |
| Dec 31, 2021 | -0.59 |
| Sep 30, 2021 | -0.57 |
| Jun 30, 2021 | -0.57 |
| Mar 31, 2021 | -0.56 |
| Dec 31, 2020 | -0.60 |
| Dec 31, 2019 | -4.23 |